Repurposing tricyclic drugs as cancer therapeutics: comparative analysis of antitumorigenic effects of chlorpromazine, amitriptyline and imipramine - Top-Institutions - MDSpire

Repurposing tricyclic drugs as cancer therapeutics: comparative analysis of antitumorigenic effects of chlorpromazine, amitriptyline and imipramine

  • By

  • Joos Berghausen

  • Eric Glasgow

  • Tinatin I. Brelidze

  • July 2, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    US Oncology Research
    US Oncology Research

    Houston, Texas

    Key Differentiators

    • Oncology

  • #2

    Juntendo University
    Juntendo University

    Tokyo, Tokyo

    Key Differentiators

    • Oncology

  • #3

    Compass Oncology
    Compass Oncology

    Portland, Oregon

    Key Differentiators

    • Oncology

  • #4

    Baylor-Sammons Cancer Center
    Baylor-Sammons Cancer Center

    Dallas, Texas

    Key Differentiators

    • Oncology

  • #5

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, Massachusetts

    Key Differentiators

    • Oncology

Original Source(s)

Repurposing tricyclic drugs as cancer therapeutics: comparative analysis of antitumorigenic effects of chlorpromazine, amitriptyline and imipramine

  • by Joos Berghausen, Eric Glasgow, Tinatin I. Brelidze

  • July 2, 2026

Related Content

Predicting overall survival in synchronous metastatic nasopharyngeal carcinoma using a stacking ensemble machine learning model: a multicenter retrospective study

EGP-Net: a lung nodule segmentation network integrating edge guidance and pyramidal multi-scale contextual attention mechanisms

Preoperative total cholesterol and axillary lymph node burden in breast cancer: an exploratory analysis with a preliminary nomogram